Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06516159
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
Validation of the MBI-C Scale in French
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Validation of the MBI-C Scale in French
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MBI-C
Brief Summary:
This study aims to validate the French version of the Mild Behavioral Impairment-Checklist MBI-C scale hypothetically effective for measuring behavioral symptoms in patients presenting with a subjective cognitive complaint or mild cognitive impairment MCI
Detailed Description:
Neuropsychiatric symptoms are common in the prodromal stage of dementia and may precede cognitive impairment Their presence in patients without cognitive impairment but with a subjective cognitive complaint or mild cognitive impairment MCI is associated with an increased risk of progression to dementia The concept of Mild Behavioral Impairment MBI was developed to identify populations at risk from the early stages of the disease MBI is characterized by long-lasting psychiatric symptoms appearing late in patients without cognitive deficits or with MCI and can precede dementia
The general hypothesis is that the French version of the Mild Behavioral Impairment-Checklist MBI-C scale has good psychometric capabilities to correctly measure behavioral symptoms in patients with subjective cognitive complaint or MCI The main objective is to verify the reliability and internal and external validity of the MBI-C score Secondary objectives include studying the prevalence of MBI and determining the best cutoff for the diagnosis of MBI in patients with MBI or subjective cognitive complaint
This is an observational national multicenter and cross-sectional study It will include 170 patients 5 per scale item or 34 items with an inclusion period of 24 months and a total research duration of 25 months Patients must be over 50 years old have had subjective cognitive complaint or mild cognitive impairment for at least 6 months and have a person who visits them at least once a week
Validation of the MBI-C scale in French could play a crucial role in the identification and early management of neurodegenerative disorders
The general hypothesis is that the French version of the Mild Behavioral Impairment-Checklist MBI-C scale has good psychometric capabilities to correctly measure behavioral symptoms in patients with subjective cognitive complaint or MCI The main objective is to verify the reliability and internal and external validity of the MBI-C score Secondary objectives include studying the prevalence of MBI and determining the best cutoff for the diagnosis of MBI in patients with MBI or subjective cognitive complaint
This is an observational national multicenter and cross-sectional study It will include 170 patients 5 per scale item or 34 items with an inclusion period of 24 months and a total research duration of 25 months Patients must be over 50 years old have had subjective cognitive complaint or mild cognitive impairment for at least 6 months and have a person who visits them at least once a week
Validation of the MBI-C scale in French could play a crucial role in the identification and early management of neurodegenerative disorders
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None